Nuwellis, Inc.
NUWE- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001506492
No open-market purchases or sales by Nuwellis, Inc. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $63.9K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Nuwellis, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 8 | 5 | −3 |
| Shares | 290.8K | 21.0K | −269.8K (−92.8%) |
| Value | $305.3K | $63.9K | −$241.4K (−79.1%) |
New holders (2)
Institutions that held Nuwellis, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sabby Management, LLC | 16,372 | $49.9K | 0.42% |
| Morgan Stanley | 35 | $107 | 0.00% |
Sold out (5)
Institutions that held Nuwellis, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Armistice Capital, LLC | 236,200 | $248.0K |
| Geode Capital Management, LLC | 44,176 | $46.4K |
| Citigroup Inc | 5,126 | $5.38K |
| Caitong International Asset Management Co., Ltd | 4 | $4 |
| Ankerstar Wealth, LLC | 1 | $1 |